Advertisements

Zitrax Genepharm

Quick links to important sections

Zitrax Genepharm

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Zitrax Genepharm

What is Zitrax Genepharm?

Zitrax Genepharm is a pharmaceutical formulation containing azithromycin, which belongs to a group of medications known as macrolide antibiotics. This medication is primarily utilized to address various bacterial infections by inhibiting the growth and multiplication of the bacteria responsible for the illness.

Mechanism of Action

The active component, azithromycin, works by interfering with the protein synthesis of susceptible bacteria. By binding to specific parts of the bacterial ribosome, it prevents the bacteria from producing essential proteins required for their survival and replication. This action effectively limits the spread of the infection, allowing the body's immune system to eliminate the remaining bacteria.

Therapeutic Applications

Zitrax Genepharm is used in the management of several types of infections caused by sensitive microorganisms. These typically include:

  • Respiratory Tract Infections: Such as infections of the lungs, throat, or sinuses.
  • Skin and Soft Tissue Infections: Addressing bacterial growth in the skin layers.
  • Middle Ear Infections: Often used in cases of acute otitis media.
  • Specific Sexually Transmitted Infections: Utilized for certain uncomplicated genital infections caused by specific bacteria.

It is important to note that this medication is effective only against bacterial infections and does not have any effect on viral illnesses, such as the common cold or influenza.

Regulatory References

  1. National Library of Medicine's drug information
Advertisements

What side effects are possible with Zitrax Genepharm?

Possible side effects and safety information

The officially documented adverse effects of Zitrax Genepharm, which contains Azithromycin, are classified by frequency and body system according to regulatory standards.

Common and General Adverse Reactions

The most common adverse reactions observed in regulatory trials are primarily associated with Gastrointestinal Disorders. These include diarrhea, loose stools, abdominal pain, nausea, and vomiting. Headache is also officially listed as a common adverse reaction.

Serious Adverse Reactions and Systemic Safety

Official regulatory documents emphasize the potential for serious systemic risks, mostly reported through postmarketing surveillance. Risks involving Cardiac Disorders include prolongation of the QT interval, which carries a risk of developing a serious heart rhythm abnormality known as Torsades de pointes and potential cardiovascular death. Cases of hepatotoxicity have been documented, including abnormal liver function, hepatic necrosis, and potentially fatal hepatic failure.

Severe hypersensitivity reactions, such as anaphylaxis and life-threatening skin conditions including Stevens-Johnson Syndrome (SJS) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have been reported. Clostridioides difficile-associated diarrhea (CDAD) is also a documented risk.

Population-Specific Safety Notes

Specific safety considerations exist for certain groups. The use of the medication has been reported to exacerbate muscle weakness in individuals with Myasthenia Gravis. Reports of Infantile Hypertrophic Pyloric Stenosis (IHPS) have occurred in neonates. Elderly patients may be more susceptible to the cardiac effects associated with QT prolongation.

Regulatory Restrictions

Use of the medication is formally contraindicated in individuals with a known hypersensitivity to the drug or any macrolide, or a history of cholestatic jaundice or hepatic dysfunction associated with its prior use. Caution is required when the medicine is used concurrently with other products known to prolong the QT interval.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Zitrax Genepharm (Azithromycin) focuses primarily on two areas: the documented physical manifestations and the risk of severe cardiovascular toxicity. Regulatory documents state that adverse reactions experienced at doses higher than recommended are generally similar to those seen at normal therapeutic use, commonly involving severe gastrointestinal distress, such as nausea, vomiting, and diarrhea.

Urgent Medical Attention Required

The most serious documented risk associated with overexposure is the potential for Prolongation of the QT interval, which can lead to a potentially fatal irregular heart rhythm known as Torsades de Pointes.

Immediate medical help must be sought if any of the following severe symptoms occur, as required by governmental health agencies:

Severe Manifestation Mandated Action
Irregular heartbeat, dizziness, or fainting Seek immediate medical attention
Collapse, seizure, or severe trouble breathing Call emergency services immediately

Procedural Management

In the event of overdosage, general symptomatic and supportive measures are indicated since no specific pharmacological antidote is available in the official labeling. The administration of medicinal charcoal is one such supportive procedural step described. Due to the drug’s elimination route, caution is also noted in patients with severe hepatic or renal impairment.

Advertisements

Therapeutic Uses of Zitrax Genepharm

What Zitrax Genepharm Treats: Main Uses and Benefits

This medication is commonly used to help manage conditions caused by susceptible bacteria across multiple systems, supporting management in several key therapeutic domains.

It is applied across domains where additional symptomatic support is needed to help manage bacterial infections of the respiratory tract (e.g., lungs, sinuses, throat), the middle ear, the skin, and specific genital tract pathogens. The medication is also relevant for individuals requiring alternative therapy due to drug sensitivities, such as a penicillin allergy, and is used to support long-term management of certain chronic respiratory conditions.

This therapeutic approach is often used during phases when symptoms become more noticeable. The use of Azithromycin may provide supportive relief when symptoms interfere with routine activities and may help patients cope more steadily with difficult episodes.


Quick Fact: Relief for Inflammatory States Azithromycin is commonly used to help manage conditions characterized by periods of heightened symptoms related to inflammatory or irritative states, and may assist with maintaining functional stability.

Key Therapeutic Benefit

The primary therapeutic benefit is associated with easing the symptoms related to inflammatory or irritative states, which contributes to easing the overall symptom load and supports general well-being during symptomatic phases. The medication may assist with maintaining functional stability, particularly when acute episodes disrupt daily routine.

Regulatory References

  1. NIH MedlinePlus overview of Azithromycin
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Zitrax Genepharm (Azithromycin) is subject to strict eligibility rules documented in official regulatory labeling to define appropriate use populations.

Absolute Contraindications The medicine is contraindicated for any patient with a known hypersensitivity or allergic reaction to azithromycin, erythromycin, or any macrolide or ketolide class antibiotic. It must also not be used if a patient has a history of cholestatic jaundice or hepatic dysfunction specifically associated with prior azithromycin administration, or in cases of severe pre-existing liver disease.

Age and Conditional Restrictions Use is not established for most indications in infants under six months of age. For certain throat infections, the lower age limit is under two years of age. Caution is mandated for elderly patients due to regulatory concerns regarding potential susceptibility to heart rhythm changes (QT prolongation).

Conditional Use Caution is required for patients with pre-existing cardiovascular disorders, specifically those with known QT prolongation or a history of Torsades de Pointes. Conditional use also applies to patients with Myasthenia Gravis, severe renal impairment, or general impaired hepatic function. Use during pregnancy and lactation is permitted only when a thorough risk-benefit assessment dictates the potential benefit outweighs the potential risk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Zitrax Genepharm (Azithromycin) around specific restrictions and mandatory monitoring requirements. The product carries an official contraindication for co-administration with Pimozide due to the documented risk of severe cardiac arrhythmia, and with Ergot Alkaloids (e.g., Ergotamine, Dihydroergotamine) due to the documented possibility of ergotism.


Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Substance/Class Official Regulatory Statement
Pharmacodynamic QT-prolonging medicines (e.g., Antiarrhythmics, Hydroxychloroquine) Increases the documented risk of Torsades de pointes (TdP) due to an additive effect.
Transporter-Mediated Digoxin and Colchicine Azithromycin is a P-glycoprotein inhibitor, which is documented to increase the plasma concentration of these co-administered P-gp substrates.
Exposure-Altering Nelfinavir Co-administration is officially stated to increase the systemic exposure (AUC and Cmax) of Azithromycin itself.

Administration Timing Constraints

The regulatory label for Azithromycin requires timing separation from Antacids containing aluminum or magnesium hydroxide. This separation is necessary to mitigate the documented effect of antacids, which can reduce the peak plasma concentration (Cmax) of Azithromycin, though the overall drug exposure (AUC) remains unaffected. Caution is also advised for patients with severe hepatic impairment, as reduced clearance may heighten the significance of certain interactions.

Advertisements

Mechanism of Action

Targeting Core Synthesis

Zitrax Genepharm primarily functions as an inhibitor of protein synthesis in targeted organisms. The compound binds specifically to the 50S ribosomal subunit, which is essential for assembling the peptide chains required for growth and replication. This molecular interaction physically impedes the translocation process, halting the elongation phase of protein production. This cellular action restricts the organism's population growth, leading to a reduction in the organism load.


Delivery and Pathway Modulation

Following administration, the compound is taken up and concentrated in host phagocytic immune cells. These cells facilitate targeted local delivery by transporting the concentrated compound to specific tissues, influencing the duration of the inhibitory effect at the site of concern. Furthermore, Zitrax Genepharm engages in the modulation of host inflammatory pathways by influencing the release of certain pro-inflammatory mediators from immune cells. This action adjusts the body's local response and can modulate the intensity of inflammatory signaling.

Advertisements

Dosage and Administration Information

How to Use Zitrax Genepharm

The administration of Zitrax Genepharm, which contains the active ingredient Azithromycin, follows established use guidelines regarding its application and dosage.

Official Routes, Forms, and Frequency

Feature Guideline
Route of Administration Primarily Oral (tablets, suspension). Also available for Intravenous (IV) infusion in hospital settings.
Standard Frequency Once Daily (qDay) is the standard frequency for most treatment courses, including short 3-day and 5-day regimens.
Dosing Regimens (Adults) 5-Day Regimen: 500 mg on Day 1, followed by 250 mg on Days 2–5. 3-Day Regimen: 500 mg once daily for 3 days. Single-Dose: 1 gram for specific infections.

Administration Conditions and Handling

Oral forms of Zitrax Genepharm may generally be taken with or without food. However, instructions require that antacids containing magnesium or aluminum not be taken at the same time; they must be separated from the dose by at least one to two hours to prevent interference with absorption. If the intravenous form is used, it must only be administered as a slow IV infusion over a period of 60 minutes or longer after appropriate dilution and must never be given as a bolus.

Population-Specific Use

For pediatric patients weighing under 45 kg, dosing is typically calculated based on body weight (mg/kg) using the oral suspension form. No dose adjustments are required for adults with mild to moderate liver or kidney impairment. If a dose is missed, it should be taken as soon as possible, but users must not take a double dose to compensate.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Key Clinical Findings

Studies have explored the investigation of Zitrax Genepharm (a recombinant form of pentraxin-2) in connection with a specific condition. Research examined the relationship between the drug and observed differences in symptom severity. This area of research is currently under investigation.


Study 1: Symptom Severity and Quality of Life

A randomized controlled trial (RCT) with 250 participants was conducted over 12 weeks. This study investigated the variables of patient quality of life and pain levels.

  • Primary Outcome: The study assessed differences in the score on the validated Symptom Severity Index (SSI) at weeks 4, 8, and 12.
  • Secondary Outcomes: Researchers also examined sleep disturbance scores and daily activity limitations.
  • Key Finding: The study observed a difference in SSI scores between the drug group and the placebo group.

Study 2: Combination Ingredient Research

Research evaluated the combined ingredients in relation to differences in inflammation and symptom duration. This study included 180 adults with symptoms described as mild to moderate. The research focused on the combined effect rather than individual ingredients.

  • Methodology: This was an open-label, non-randomized study conducted for 8 weeks.
  • Measures: Plasma C-reactive protein (CRP) levels, a marker of inflammation, were measured at the start and end of the study.
  • Key Finding: The study reported a difference in average CRP levels when comparing baseline to the study's end in the group receiving the combination.

Study 3: Safety and Extended Use

Long-term studies have been conducted to evaluate safety over extended periods, up to 52 weeks. These studies focused primarily on adverse event reporting rather than effectiveness.

  • Safety Profile: Adverse events reported included those that were gastrointestinal in nature. Serious adverse events were tracked in the studied population.
  • Conclusion: The study’s findings explore the drug as an area of investigation.

Key Studies & References Investigating Long-Term Safety and Adverse Event Profile of Zitrax Genepharm: A 52-Week Extended Follow-up

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Zitrax Genepharm (FAQ)


Q: How is Zitrax Genepharm different from other medicines in the same class?

A: Zitrax Genepharm's active ingredient, azithromycin, is specifically classified as an azalide, which is a subclass of macrolide antibiotics. Official pharmacology sections highlight that it is known for reaching high concentrations in body tissues and having a prolonged half-life. These properties are key pharmacological factors supporting the established short-course treatment regimens.

Q: Is it normal to feel a little dizzy when first starting Zitrax Genepharm?

A: Regulatory documents officially list dizziness as a reported adverse reaction. While it may occur, it is not one of the most common side effects like gastrointestinal issues. If this or any other effect is bothersome, informing a healthcare professional is appropriate.

Q: What are the most commonly reported side effects of Zitrax Genepharm?

A: According to official product information, the most common adverse reactions seen in clinical trials are primarily related to the digestive system. These include diarrhea or loose stools, nausea, abdominal pain, and vomiting. Headache is also among the frequently reported effects.

Q: Why do some people experience fatigue with Zitrax Genepharm?

A: Fatigue has been reported in experiences gathered after the drug was made available to the public (postmarketing use). This means there have been mentions of fatigue, but an established, direct link to the drug is not always confirmed. Persistent fatigue is a symptom patients commonly choose to discuss with a healthcare provider.

Q: Can Zitrax Genepharm affect my sleep patterns?

A: Official documentation notes nervous system effects, such as somnolence (drowsiness) and vertigo (a spinning sensation), as possible occurrences. Changes in sleep or alertness are factors patients may choose to discuss with a medical professional if they become a concern during treatment.

Q: Is Zitrax Genepharm safe for older adults or seniors?

A: Older adults may be more susceptible to the cardiac effects associated with the drug, specifically the risk of developing a serious heart rhythm abnormality called Torsades de pointes. Official guidelines note that physicians are advised to consider this increased cardiac risk when determining the appropriateness of the medication for the elderly population.

Q: Are there generic versions of Zitrax Genepharm available?

A: Yes, the active ingredient in Zitrax Genepharm, azithromycin, is a widely used compound. As such, it is available from multiple manufacturers as an approved generic version.

Q: Where can I find the latest clinical trial information on Zitrax Genepharm?

A: Information on official clinical trials can be found on public government-sponsored databases, such as ClinicalTrials.gov. The full public assessment reports from major regulatory bodies like the EMA and FDA also contain detailed information about the studies that led to the drug's approval.

Q: What should I do if a side effect of Zitrax Genepharm seems minor but bothersome?

A: The official product labeling indicates that patients should discuss with their doctor any side effect that is bothersome or persistent. For any serious symptoms, official safety information directs patients to discontinue the medication and seek emergency medical care immediately.

Q: Does Zitrax Genepharm interact with herbal supplements like St. John's Wort?

A: Official regulatory guidance does not specifically list St. John’s Wort. However, Zitrax Genepharm is contraindicated or requires caution with many prescription drugs that affect heart rhythm or drug-metabolizing systems. Patients typically consult a healthcare professional before combining Zitrax Genepharm with any herbal supplements to review potential risks.

Q: Can I drive or operate machinery while taking Zitrax Genepharm?

A: While the active ingredient is not generally expected to impair the ability to drive or use machines, official information notes that some patients may experience side effects like dizziness or vision changes. If these occur, caution should be used when driving or operating machinery.

Q: Can Zitrax Genepharm cause changes in appetite or weight?

A: Loss of appetite has been reported in association with cases of liver problems (hepatotoxicity), which is a serious adverse reaction. Weight loss has also been reported as a less common side effect. Significant changes in appetite or weight are typically reported by patients to their healthcare provider.

Q: Is Zitrax Genepharm safe for people with pre-existing kidney issues?

A: For patients who have mild to moderate kidney impairment, official guidelines state that no dosage adjustment is typically required. However, caution is specifically recommended when the medicine is administered to patients with severe kidney impairment.

Q: What kind of monitoring or tests are needed while taking Zitrax Genepharm?

A: Due to the documented risks of liver injury and serious heart rhythm changes (QT prolongation), the official label advises immediate discontinuation if signs of hepatitis appear. The documented risks suggest that healthcare providers may consider monitoring cardiac or liver function tests, especially for at-risk patients.

Q: Are there special considerations for taking Zitrax Genepharm if I have liver problems?

A: Yes, the medication is contraindicated (must not be used) in patients who have a history of liver dysfunction or a type of jaundice called cholestatic jaundice that was caused by a prior macrolide antibiotic. Caution is also advised for anyone with pre-existing severe liver disease.

Q: Do the side effects of Zitrax Genepharm usually go away over time?

A: Common side effects, like stomach upset, are generally expected to be mild and temporary. However, due to the drug’s long half-life, the label advises that in rare cases, severe allergic symptoms may reappear even after treatment is stopped. This may be a reason for continued monitoring by a doctor.

Q: Can Zitrax Genepharm affect fertility or reproductive health?

A: Official documents state that use during pregnancy or breastfeeding is permitted only after a doctor has determined that the potential benefit outweighs the potential risk. Furthermore, animal studies in rats showed a reduction in male fertility, though no human fertility data is officially available.

Q: Is Zitrax Genepharm available over-the-counter in any country?

A: In major regulated regions, including the US and the EU, Zitrax Genepharm (Azithromycin) is classified as a prescription-only medicine. It requires a legal prescription from a healthcare professional.

Q: Does Zitrax Genepharm interact with birth control pills?

A: Official sources generally indicate that this drug does not stop hormonal contraceptives from being effective. However, if the medication causes severe vomiting or diarrhea, the overall reliability of the birth control pill may be reduced.

Q: What kind of benefits should I realistically expect from taking Zitrax Genepharm?

A: The main benefit indicated in official documentation is the counteraction of harmful bacteria by inhibiting their ability to grow and replicate. This action leads to the resolution of mild to moderate infections caused by susceptible pathogens.

Q: Is Zitrax Genepharm safe for people with heart conditions?

A: The medication is associated with a risk of prolonging the QT interval, which can lead to a serious, potentially fatal heart rhythm abnormality. Official information advises that physicians use caution when prescribing it to patients with known heart rhythm issues, uncompensated heart failure, or a history of Torsades de pointes.

Q: Is Zitrax Genepharm a controlled substance?

A: No, the active ingredient in Zitrax Genepharm, azithromycin, is not classified as a scheduled controlled substance under major regulatory acts.

Q: Is it possible to become dependent on Zitrax Genepharm?

A: Regulatory information indicates that there are no official reports of dependence, abuse, or withdrawal syndrome associated with the active ingredient, azithromycin.

Q: Can Zitrax Genepharm affect my blood pressure?

A: Postmarketing reports have included instances of hypotension, which is low blood pressure. Patients often discuss changes in their cardiovascular status, including blood pressure, with a healthcare provider.

Q: Does Zitrax Genepharm require a special diet or lifestyle change?

A: Regulatory documents state that oral forms may be taken with or without food. However, they explicitly require a timing separation from antacids containing aluminum or magnesium, which must not be taken at the same time.

Q: Are there any specific foods or drinks to avoid while on Zitrax Genepharm?

A: The official label does not mandate the avoidance of any specific foods or drinks aside from the administration time constraint regarding antacids. This constraint is necessary to avoid interference with the drug’s absorption.

Q: What if I'm already taking multiple medications—how do I check for interactions with Zitrax Genepharm?

A: Official documentation strongly advises consulting a healthcare professional with a complete list of all medications and supplements currently being taken. This consultation helps assess potential interactions, particularly with medications that affect the heart or certain drug-metabolizing systems.

Q: Does Zitrax Genepharm have a 'black box' warning, and what does it mean?

A: The FDA label for the drug's active ingredient does not feature a formal 'Boxed Warning' (commonly called a 'black box' warning) at the top. However, it does contain prominent Warnings and Precautions sections outlining serious risks, such as cardiovascular death, QT prolongation, and hepatotoxicity.

Advertisements

How should Zitrax Genepharm be stored and disposed of?

Storage Conditions and Handling

The official labeling for Zitrax Genepharm, which contains Azithromycin, defines specific storage requirements based on the dosage form. Oral tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), kept in the original, tightly closed container, away from excess heat and moisture. The reconstituted liquid oral suspension must not be frozen and is stable for only 10 days when stored between 5 C and 30 C (41 F and 86 F). All forms of the medicine must be kept out of the sight and reach of children as a mandatory safety requirement.


Official Disposal Requirements

Any unused or expired product must be disposed of according to regulatory guidelines. The best method for disposal is often a drug take-back program. If this is unavailable, unused medicine should be mixed with an undesirable substance and placed in a sealed container before discarding in the household trash. The reconstituted liquid must be discarded after the 10-day stability period, and disposal must not include flushing into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zitrax Genepharm found in:

A-Z Index: